Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Código da empresaEVO
Nome da EmpresaEvotec SE
Data de listagemOct 11, 1999
Fundado em2019
CEODr. Christian Wojczewski
Número de funcionários4827
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 11
EndereçoEssener Bogen 7
CidadeHAMBURG
Bolsa de valoresOMX Nordic Exchange Stockholm AB - cash
PaísGermany
Código postal22419
Telefone4940560810
Sitehttps://www.evotec.com/
Código da empresaEVO
Data de listagemOct 11, 1999
Fundado em2019
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados